Request for Reconsideration Template

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

Contact:

• Therapeutic Products Directorate
• Biologics and Genetic Therapies Directorate

December 18, 2006

Notice

Our file number: 06-128748-722

The Request for Reconsideration Template has been separated from the Health Canada guidance document Reconsideration of Final Decisions Issued for Human Drug Submissions and is now available on the Health Canada website. Other than the removal of the template, the guidance document itself has not changed.

Should you have any questions regarding the content of the template or the guidance document, please contact:

Office of Science
Bureau of Policy, Science and International Programs
Therapeutic Products Directorate
Holland Cross, Tower B, A.L. 3102C3
1600 Scott Street
Ottawa, ON K1A 0K9

Tel: (613) 948-4623
Fax: (613) 941-1812
E-mail: Policy_Bureau_Enquiries@hc-sc.gc.ca

Office of Quality and Risk Management
Biologics and Genetic Therapies Directorate
Health Protection Building, A.L. 0702E
200 Tunney's Pasture Driveway
Ottawa, ON K1A 0K9

Tel: (613) 946-5434
Fax: (613) 946-5214
E-mail: BGTD_DGO_Enquiries@hc-sc.gc.ca